Simultaneous Determination of Isoniazid and Acetylisoniazid in Human Plasma by Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetics Related to N-Acetyltransferase2 Genetic Polymorphism
- 30 April 2012
- journal article
- research article
- Published by Taylor & Francis in Analytical Letters
- Vol. 45 (15) , 2125-2135
Abstract
A rapid, sensitive, and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with hydrophilic interaction chromatography has been developed and validated for the simultaneous determination of isoniazid and acetylisoniazidin human plasma. Following precipitation of the protein, the analytes were extracted from human plasma, with high extraction recovery (>70%) for both Isoniazid and acetylisoniazid. The analytes were then separated using a hydrophilic interaction chromatography (HILIC) column and detected by electrospray ionization (ESI) mass spectrometry performed with a triple-quadrupole mass spectrometry. The quantification of the analytes was realized by low-energy collision dissociation tandem mass spectrometry (CID-MS/MS) using the multiple reaction monitoring (MRM) mode at m/z of 138.1→121.1 for isoniazid and m/z 180.1 → 138.1 for acetylisoniazid, respectively. The method was linear over the concentration range of 5–50,000 ng/mL for both. The intra-day and inter-day relative standard deviations (RSD) were less than 15% and the relative errors (RE) were all within 15%. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic studies of isoniazid related to NAT2 genetic polymorphism in healthy Chinese subjects. The results showed that there were significant differences in the pharmacokinetic parameters of isoniazid and acetylisoniazid between subjects with and without mutations in the NAT2 gene.Keywords
This publication has 13 references indexed in Scilit:
- Isoniazid Prophylaxis against Tuberculosis in ChildrenNew England Journal of Medicine, 2011
- Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed ChildrenNew England Journal of Medicine, 2011
- In Silico Children and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with TuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantationTransplant International, 2010
- Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravisRheumatology International, 2009
- Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography–tandem mass spectrometry with on-line extractionJournal of Chromatography B, 2007
- Neuropathie toxique induite par l’isoniazide : pensez à la préventionRevue des Maladies Respiratoires, 2006
- Direct injection of solid‐phase extraction eluents onto silica columns for the analysis of polar compounds isoniazid and cetirizine in plasma using hydrophilic interaction chromatography with tandem mass spectrometryRapid Communications in Mass Spectrometry, 2004
- Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitisHepatology, 2002
- High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1995